About GLP-3 (GLP-3)
GLP-3 is the research designation for GLP-3, a triple-receptor agonist that simultaneously targets GIP (glucose-dependent insulinotropic polypeptide), GLP-1 (glucagon-like peptide-1), and glucagon receptors. This tripartite mechanism distinguishes it from earlier dual-receptor compounds and positions it as one of the most comprehensive metabolic research tools available.
The compound operates across three complementary pathways: GLP-1 receptor activation slows gastric emptying and reduces appetite signaling; GIP receptor activation enhances insulin secretion and may contribute to adipose tissue remodeling; glucagon receptor activation promotes hepatic glucose output and energy expenditure. Research into the combined effects of these three mechanisms is ongoing and represents a significant area of interest in metabolic science.
Research Applications
GLP-3 (GLP-3) is used in metabolic research investigating multi-receptor incretin pathway modulation. Research applications include studies of appetite regulation, energy homeostasis, insulin sensitivity, glucagon pathway interactions, and body composition under conditions of triple-receptor agonism. The compound is of particular interest in research comparing dual vs. triple receptor agonist mechanisms.